Overview

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

Status:
Completed

Trial end date:
2017-11-01

Target enrollment:

Participant gender:

Summary

This study seeks to evaluate safety and efficacy of Nelotanserin for the treatment of visual hallucinations in subjects with Lewy body dementia.

Phase:

Phase 2

Details

Lead Sponsor:

Axovant Sciences Ltd.